back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-02-13 13:57 Tx date 2026-02-09 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$249,975
+24,750 vol $10.10 each |
681,333 | |
| Filed 2026-02-13 13:29 Tx date 2026-01-30 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-7,222,417 vol |
656,583 | |
| Filed 2026-02-13 13:28 Tx date 2026-01-30 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-205,120 vol |
18,645 | |
| Filed 2025-06-23 14:00 Tx date 2025-06-18 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,850
+110,637 vol $0.55 each |
223,765 | |
| Filed 2025-01-15 11:02 Tx date 2025-01-09 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,787
+56,890 vol $0.84 each |
113,128 | |
| Filed 2024-12-20 17:11 Tx date 2024-12-20 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$288,000
+320,000 vol $0.90 each |
7,879,000 | |
| Filed 2024-10-09 17:52 Tx date 2024-10-09 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$427,499
+750,000 vol $0.57 each |
7,559,000 | |
| Filed 2024-03-27 16:58 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
113,793 | |
| Filed 2023-11-22 16:51 Tx date 2023-11-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$134,821
+23,529 vol $5.73 each |
784,404 | |
| Filed 2023-11-09 16:02 Tx date 2023-11-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$98,661
+16,471 vol $5.99 each |
760,875 | |
| Filed 2023-11-09 16:01 Tx date 2023-11-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$321,240
+60,000 vol $5.35 each |
744,404 | |
| Filed 2023-09-12 20:43 Tx date 2023-09-07 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,057
+56,238 vol $0.41 each |
56,238 | |
| Filed 2023-09-12 20:41 Tx date 2023-06-29 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-12 20:41 Tx date 2023-06-29 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,809,000 | ||
| Filed 2023-03-23 21:06 Tx date 2023-03-21 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+36,000 vol |
224,889 | |
| Filed 2023-01-05 13:36 Tx date 2022-12-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-83,088.28
-34,334 vol $2.42 each |
684,404 | |
| Filed 2023-01-05 13:36 Tx date 2022-12-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-91,312.49
-37,889 vol $2.41 each |
718,738 | |
| Filed 2023-01-05 13:35 Tx date 2022-12-20 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-110,351.01
-43,617 vol $2.53 each |
756,627 | |
| Filed 2023-01-05 13:34 Tx date 2022-12-16 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-133,500
-50,000 vol $2.67 each |
800,244 | |
| Filed 2023-01-05 13:33 Tx date 2022-12-15 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-143,000
-50,000 vol $2.86 each |
850,244 |